- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
FAQ: The 'Doc Fix' Dilemma
Among the must-do issues on Congress’ end of year list is the "doc fix" — billions of dollars needed to avert drastic rate cuts for physicians who treat Medicare’s 48 million beneficiaries.
For doctors, the nail-biter has become a familiar but frustrating rite. Lawmakers invariably defer the cuts prescribed by a 1997 reimbursement formula, which everyone agrees is broken beyond repair. But the deferrals are temporary, and the doc fix has become increasingly difficult to push through a divided and deficit-wary Congress. Last year, Congress delayed scheduled cuts 5 times, with the longest patch lasting 1 year.
The script is no different heading into 2012. Should lawmakers fail to reach agreement before returning home for the holidays, a half million doctors will face a 27% cut beginning Jan. 1. Although Democratic and Republican leaders have pledged to stop that from happening, they disagree over how to offset the costs of a fix. While there is little doubt some agreement will be reached, a deal could be delayed until early 2012.
Click here to read some answers to frequently asked questions about the doc fix: http://www.kaiserhealthnews.org/Stories/2011/December/15/FAQ-Doc-Fix.aspx
Source: Kaiser Health News
Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM
March 21st 2025Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Overcoming CAR T Manufacturing Failure in LBCL
March 21st 2025Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen receptor (CAR) T-cell administration in patients with relapsed/refractory large B-cell lymphoma (LBCL).
Read More
